جست‌وجوی استاد و پژوهشگر

Johan Lundinمشاهده پروفایل

استاد

• Medical Technology
• Artificial Intelligence in Healthcare
• Global Health
• +۳ مورد دیگر

Johan Lundin is a Professor of Medical Technology at the Department of Global Public Health, Karolinska Institutet, and Research Director at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki. His research focuses on digital diagnostics and artificial intelligence (AI) for improving patient care, particularly in resource-limited settings. Key areas include image-based diagnostics for cancer, infectious diseases, and burn injuries, with an emphasis on point-of-care solutions. He holds a Docent title from the University of Helsinki (2003). Lundin leads the MoMic Project, supported by a 10M SEK grant from the Erling-Persson Family Foundation, which develops AI-driven mobile microscopy for diagnostics in collaboration with Kenyan partners. His work includes validation studies in Kenya on cervical cancer screening, helminth infection monitoring, and malaria treatment efficacy. Lundin’s research group has pioneered cloud-based platforms like the WebMicroscope and mobile microscopy tools. He collaborates internationally, including with Uppsala University and Kinondo Kwetu Hospital in Kenya, under the GlobeLife initiative. His scientific contributions span over 150 peer-reviewed articles in journals like PLOS Digital Health, Nature, and Lancet Public Health. Awards include the Erling-Persson Family Foundation Grant (2021-2024), recognizing his innovation in global health diagnostics. His future work aims to scale AI diagnostics to enhance equity in healthcare access through sustainable technologies.

Klaus-Martin Schulteمشاهده پروفایل

استاد

• Indigenous Pharmacogenomics
• Space Medicine
• Cancer Biology
• +۳ مورد دیگر

Prof. Klaus-Martin Schulte is the Professor & Chair of Transdisciplinary Health Research at the Australian National University (ANU) and holds an Honorary Reader position at King's College London. His clinical roles include Consultant Endocrine and General Surgeon at King’s College Hospital (part-time since 2014) and Lead Clinician in Endocrine Surgery. He has extensive experience in surgical oncology, endocrine disorders, and translational research. Education: MD from University of Duisburg-Essen (1990) Postgraduate training at Harvard Medical School, Baylor College of Medicine, and University of Paris PhD in molecular endocrinology (1990) FRACS (Fellow of the Royal Australasian College of Surgeons) and FRCS (Fellow of the Royal College of Surgeons of England) Research Interests: Focus on Indigenous Pharmacogenomics , Space Medicine , and Cancer Biology . His work includes developing surgical oncology protocols for endocrine cancers (e.g., parathyroid carcinoma, pheochromocytoma) and investigating space-related health challenges like microgravity effects on cardiovascular systems. Key Projects: iLAuNCH: Wearable health solutions for space medicine Pharmacogenomics pipeline for Indigenous health equity Software-defined radio for satellite communications Awards: von Langenbeck Award for surgical innovation (2002) Oberdisse Award for thyroid research (1998) Multiple Clinical Excellence Awards (2004–present) Grants & Funding: Principal investigator in 4 DFG-funded projects and multiple NHMRC-like grants. Current leadership roles in ANU’s Transdisciplinary Health Research division. Future Work: Expanding space medicine collaborations and advancing precision medicine for endocrine tumors.

Kelechi Njokuمشاهده پروفایل

عضو هیئت علمی

• Endometrial Cancer
• Biomarker Research
• Proteomics
• +۶ مورد دیگر

Dr. Kelechi Njoku is an NIHR Clinical Lecturer in Cancer Diagnostics and Machine Learning at the University of Manchester, and an Academic Futures Scholar in Evidence-Based Health Care at the University of Oxford. He holds an honorary Clinical Oncology Specialist Registrar position at Christie NHS Foundation Trust. His research focuses on biomarker discovery for endometrial and ovarian cancers using proteomics and machine learning, with a particular emphasis on non-invasive diagnostic approaches. Education includes a PhD in Cancer Sciences (University of Manchester), a Master's in Public Health (Newcastle University), and a Post-graduate Certificate in Health Research (University of Leeds). He is a member of the Royal College of Physicians (MRCP) and has been awarded prestigious fellowships from Cancer Research UK and the Wellcome Trust. Research interests span biomarker development, proteomics, data science, and cancer epidemiology. Key achievements include the Edgar Gentilli Prize for cancer research and the Sir William Gilliatt Award for outstanding academic presentations. His work contributes to UN Sustainable Development Goals related to improving health equity and reducing cancer mortality. Recent publications explore urinary biomarkers, SWATH proteomic profiling, and machine learning-driven diagnostic tools. He collaborates internationally on projects like the DETECT study for endometrial cancer detection. Grants include support from the Eve Appeal and North West Cancer Research. Dr. Njoku leads projects on biomarker validation and clinical translation, with active lab involvement in proteomic analysis and computational biology. Future work aims to integrate AI into diagnostic workflows to improve cancer patient outcomes.

Wolfgang Lindenمشاهده پروفایل

استاد

• Health Psychology
• Cardiac Rehabilitation
• Cancer Care Psychology
• +۳ مورد دیگر

Dr. Wolfgang Linden is a Professor Emeritus at the University of British Columbia's Department of Psychology within the Faculty of Arts. He holds a Diploma in Clinical Psychology from Münster University (1975) and a Ph.D. in Clinical Psychology from McGill University (1981). As a scientist-practitioner, his work focuses on health risk behavior reduction, hypertension treatment, psychosocial cardiac rehabilitation, and psychological aspects of cancer care. He has authored over 170 peer-reviewed articles, seven books, and an influential undergraduate textbook in clinical psychology (now in its third edition). Education Diploma in Clinical Psychology, Münster University, Germany (1975) Ph.D. in Clinical Psychology, McGill University, Montreal (1981) Research Interests Dr. Linden’s research spans experimental and clinical studies on disease mechanisms, clinical trials, and systematic reviews. Key areas include: Health risk behavior interventions Psychosocial factors in cardiovascular and cancer care Advocacy for mental health service improvements Minimizing adverse childhood events’ lifelong health impacts His work emphasizes translational research, bridging clinical practice and scientific inquiry. Awards & Recognition Recipient of the: Senior Investigator Award (Canadian Psychological Association, 2018) American Psychological Association Fellow (2001) Advocacy & Leadership Past president of both the British Columbia and Canadian Psychological Associations, Dr. Linden has dedicated four decades to advocacy for systemic mental health reforms. Currently focuses on reducing adverse childhood experiences’ societal health burden. Labs & Collaborations Collaborations include the Provincial Heart Centre, British Columbia Cancer Agency, and cardiac transplant teams. His work frequently intersects with clinical settings, emphasizing real-world applicability of research findings.

• Immunology
• Inflammation
• Inflammasome
• +۲ مورد دیگر

Luke O'Neill serves as an Honorary Professor at the Institute for Molecular Bioscience, University of Queensland, where his research centers on molecular immunology and inflammatory disease mechanisms. His work bridges fundamental immunology with translational applications across diverse pathological contexts. His primary research domains include: Immunology Inflammation Inflammasome biology Molecular bioscience Innate immunity Analysis of his publication record (2010-2017) reveals a concentrated focus on NLRP3 inflammasome dysregulation in diseases ranging from asthma and Alzheimer's to viral infections and metabolic disorders. His contributions include seminal work on the inhibitor MCC950, demonstrating therapeutic potential across neurodegenerative, respiratory, and autoimmune conditions through precise modulation of inflammatory pathways. Scientific Awards: No awards were documented in the provided text. Advising and Grants: While the text confirms active research leadership through extensive co-authorship networks, specific student mentorship details or grant funding information remain unreported. Labs and Teams: Affiliated with the University of Queensland's Institute for Molecular Bioscience, his collaborative framework spans international institutions including Trinity College Dublin and research groups across Europe and North America, though specific lab configurations are not described.

Vafa Tabatabaieمشاهده پروفایل

استاد

• Osteoporosis
• Metabolic Bone Disease
• Thyroid Disorders
• +۵ مورد دیگر

Dr. Vafa Tabatabaie is a Professor in the Departments of Medicine (Endocrinology) and Orthopaedic Surgery at Albert Einstein College of Medicine. She serves as Interim Chief of the Division of Endocrinology and Director of the Fracture Liaison Service at Montefiore Medical Center. Her research focuses on osteoporosis prevention, metabolic bone disease, thyroid cancer, and endocrine issues in older adults. She also co-founded the Transgender Interest Group at Montefiore/Einstein. Education: M.D., Shahid Beheshti University of Medical Sciences (Tehran, Iran) Internal Medicine Residency, Montefiore Medical Center (2011) Endocrinology Fellowship, Montefiore Medical Center (2013) Research Interests: Secondary prevention of osteoporotic fractures via multidisciplinary teams Thyroid cancer epidemiology and treatment outcomes Endocrine disorders in aging populations Impact of testosterone therapy in older men Key Contributions: Developed Montefiore's Fracture Liaison Service Published extensively on metabolic bone disease, thyroid disorders, and transgender health Mentored over 20 residents and fellows in clinical research Awards: Leo M. Davidoff Society Member (2019) Department of Medicine Humanism Award (2018) Award for Outstanding House Officer (2011) Current Roles: Clinical Director, Einstein Montefiore Division of Endocrinology Director, Transgender Interest Group Leadership in Montefiore's Geriatric-Endocrine-Orthopedic collaboration

Omer Azizمشاهده پروفایل

استاد

• Surgical Oncology
• Peritoneal Malignancies
• Cytoreductive Surgery
• +۲ مورد دیگر

Professor Omer Aziz holds a Manchester Academic Health Science Centre Honorary Clinical Chair at the University of Manchester and serves as Consultant Colorectal Surgeon at The Christie NHS Foundation Trust. He specializes in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for peritoneal malignancies, performing approximately 200 procedures annually. His research focuses on surgical oncology, biomarker development, and medical technology innovation. Education: Fellow of the Royal College of Surgeons PhD, Imperial College London MBBS, Imperial College London BSc, Imperial College London Research Focus: Professor Aziz leads translational research on peritoneal tumors at the Manchester Cancer Research Centre, with particular expertise in pseudomyxoma peritonei treatment and surgical innovation. His work integrates evidence synthesis techniques to guide healthcare policy and develops novel surgical technologies. Awards & Grants: CRUK Accelerator Award for pseudomyxoma peritonei biomarkers NIHR HTA grant for CRS/HIPEC cost-effectiveness Innovate UK funding for surgical device development Medical Research Council support for colorectal cancer research Innovation: Co-founder of Smart Surgical Appliances Ltd developing sensor-enabled technologies to advance minimally invasive surgery techniques.

Edward Hartsoughمشاهده پروفایل

دانشیار

• Cancer Biology
• Melanoma Metastasis
• BRAF Signaling Pathway
• +۴ مورد دیگر

Edward J. Hartsough, PhD, is an Associate Professor in the Department of Pharmacology & Physiology at Drexel University College of Medicine. His research focuses on cancer metastasis mechanisms, particularly in melanoma, and targeted therapeutics resistance. He leads the Hartsough Lab, investigating CADM1 tumor suppression, BRAF/MEK pathway dynamics, and immune microenvironment interactions. Education: PhD in Pathology, Boston University BS in Cellular Biology and Molecular Genetics, University of Maryland Research Interests: Dr. Hartsough explores mechanisms of melanoma metastasis and therapeutic resistance, including CADM1's role in invasion suppression and immune modulation. His lab studies BRAF mutations and inhibitor responses, with a focus on MEK signaling and pyroptosis. Recent work highlights CADM1 as a diagnostic/prognostic marker and therapeutic target in melanoma. Awards: Early Career Basic Science Investigator Award (2024) NIH Pathway to Independence Award (2017) American Cancer Society Grant (2018) Labs/Teams: He directs the Hartsough Lab , collaborating with institutions like Thomas Jefferson University and the Sidney Kimmel Cancer Center. Research integrates molecular biology, immunology, and clinical models to advance melanoma therapies.

Ayse Aytamanمشاهده پروفایل

استاد بالینی

• Gastroenterology
• Hepatology
• Liver Cancer
• +۵ مورد دیگر

Ayse Aytaman, MD, is a Clinical Professor of Medicine at SUNY Downstate Medical Center and Chief of Gastroenterology and Hepatology at the VA NY Harbor Health Care System’s Brooklyn Campus. She holds leadership roles including Co-Director of the VISN 2 South Liver Team and founder of the National VA Liver Cancer Team. Her clinical focus includes general gastroenterology, hepatitis management, and advanced liver disease. Dr. Aytaman earned her MD from the University of Vienna School of Medicine, followed by residency and fellowship training at SUNY Downstate. She has pioneered initiatives such as the VA’s first multi-facility ECHO Tumor Board and a national mentorship program for HCV management. Her research emphasizes outcomes research, hepatocellular carcinoma surveillance, and healthcare cost analyses. Recognition includes the Federal Employees Team of the Year Award 2017, ACG Special Service Award, and the first female recipient of the American Liver Foundation’s Physician of the Year (2018). She is a nationally recognized educator, having mentored over 200 gastroenterology fellows and developed hepatology curricula for VA fellowship programs. Dr. Aytaman’s contributions extend to tele-hepatology outreach, mobile health screening programs, and advocacy through the Empire Liver Foundation. She actively serves on national committees for the VA, American Association for the Study of Liver Diseases, and American College of Gastroenterology.

Gabriella D'Oraziمشاهده پروفایل

دانشیار

• Molecular Oncology
• Tumor Suppressor p53
• HIPK2 Regulation
• +۳ مورد دیگر

Gabriella D'Orazi is an Associate Professor at UniCamillus University of Rome, specializing in General Pathology. She holds a PhD in Experimental Medicine (1992) from the University of Rome La Sapienza and a Master's in Dietetics and Human Nutrition (2003). Her career includes roles as a University Researcher (1992–2017) and Associate Professor (2017–2024) at the University ‘G. D’Annunzio’ of Chieti, alongside visiting appointments at the National Cancer Institute (NCI, NIH, Bethesda) and the National Cancer Institute ‘Regina Elena’ in Rome. Her research focuses on Molecular Oncology, particularly the regulatory mechanisms of tumor suppressor p53 and HIPK2 in cancer progression and therapy response. She has authored over 137 peer-reviewed publications (H-index: 47), is a member of editorial boards for international journals, and is recognized as a Top Italian Scientist in Biomedical Sciences (2024). Teaching responsibilities include Pathology and Pathophysiology across multiple degree programs at UniCamillus, as well as roles in academic governance, such as coordinating courses and serving on commissions. Her work integrates translational research, drug development, and interdisciplinary approaches to cancer biology.

• Childhood Cancer
• Molecular Oncology
• Genetic Mutations
• +۳ مورد دیگر

Kenneth S. Chen serves as an Assistant Professor of Pediatrics at UT Southwestern Medical Center and is an Attending Physician in the Gill Center for Cancer and Blood Disorders at Children's Medical Center Dallas. His dual role bridges clinical care for pediatric cancer and blood disorder patients with foundational research in childhood tumor biology. His academic training includes: B.S.E. in Biomedical Engineering from Johns Hopkins University M.D. from UT Southwestern Medical Center Pediatric Residency and Hematology-Oncology Fellowship at UT Southwestern Medical Center Dr. Chen's research centers on RNA dysregulation in childhood cancers , specifically investigating how mutations in microRNA processing genes (DROSHA, DICER1) drive tumorigenesis in Wilms tumor, pleuropulmonary blastoma, and germ cell tumors. His laboratory explores the genetic mechanisms impairing mRNA production/degradation and identifies therapeutic vulnerabilities arising from these defects, with emphasis on IGF2 regulation, WNT signaling, and proteasome pathways. Analysis of his 2023-2025 publications reveals a dominant focus on DICER1-related tumor syndromes across multiple tumor types. Key trends include therapeutic targeting of RAS/WNT pathways in sarcomas, proteasome inhibition for chemoresistant Wilms tumor, and immunotherapy combinations to reduce radiation toxicity. His work consistently connects molecular defects in RNA processing to clinical manifestations and treatment strategies. As Principal Investigator of the Chen Lab at UT Southwestern, he leads a research program dedicated to translating discoveries in RNA biology into novel therapies for childhood cancers. The lab actively recruits researchers to investigate mRNA dysregulation mechanisms and therapeutic exploitation strategies.

Katharina Harms-Effenbergerمشاهده پروفایل

پژوهشگر

• Cancer Research
• Oncology
• Molecular Biology
• +۳ مورد دیگر

Katharina Harms-Effenberger is the Head of Research Group at the Institute of Tumor Biology within the Center for Experimental Medicine at the University Medical Center Hamburg-Eppendorf (UKE). She specializes in oncology and molecular diagnostics, focusing on cancer biomarkers, liquid biopsy techniques, and metastasis mechanisms. Her work spans multiple cancers including cervical, pancreatic, esophageal, and lung cancers, with a strong emphasis on clinical applications and prognostic modeling. Her research integrates molecular pathology, genomic analysis, and clinical outcomes to improve diagnostic accuracy and patient stratification. Key areas include circulating tumor cells (CTCs), disseminated tumor cells (DTCs), and epigenetic biomarkers like DNA methylation. She collaborates with institutions like the European Liquid Biopsy Society (ELBS) to advance translational research. Publications highlight contributions to CTC-based risk stratification, liquid biopsy validation, and the role of genetic markers in cancer progression. Her work bridges basic science and clinical practice, aiming to translate molecular findings into actionable diagnostics and therapies.

Mahmoud Labibمشاهده پروفایل

مدرس

• Cancer Diagnostics
• Nanotechnology
• Biomedical Engineering
• +۳ مورد دیگر

Dr. Mahmoud Labib is a Lecturer at the Peninsula Medical School (Faculty of Health) at the University of Plymouth. His expertise lies in developing innovative diagnostic and therapeutic approaches for cancer, leveraging nanotechnology and microfluidics. He holds a Ph.D. in Biotechnology from Lund University (2009) and has conducted postdoctoral research across institutions in Canada, the US, and the UK, including roles at the University of Toronto and Northwestern University. Education: Ph.D. in Biotechnology, Lund University, Sweden (2009) Postdoctoral Studies: Western University (Canada), University of Ottawa (Canada), University of Toronto (Canada), and Northwestern University (USA) Research Interests: Dr. Labib focuses on advancing cancer diagnostics and therapeutics , with a particular emphasis on nanotechnology-based platforms for detecting biomarkers in liquid biopsies. His work integrates microfluidic devices, immunomagnetic cell sorting, and aptamer technologies to profile rare cells such as circulating tumor cells and tumor-reactive lymphocytes. His innovations aim to improve early detection, precision medicine, and therapeutic delivery systems. Articles Trends: His recent publications highlight advancements in microfluidic systems for high-throughput screening, magnetic cytometry for rare cell analysis, and nanomaterial-enabled detection of cancer-related biomarkers. These studies underscore his contribution to translating nanotechnology into clinical diagnostics. Labs/Teams: His research is conducted within the Peninsula Medical School’s interdisciplinary environment, collaborating with teams specializing in biomedical engineering and oncology. His lab develops cutting-edge tools for single-cell analysis and biomarker discovery. Teaching: At Plymouth, he teaches modules in physiology, renal systems, and cardiac muscle biology to medical and diagnostic radiography students.

Nikitas Nikitasمشاهده پروفایل

مدرس

• Intensive Care Medicine
• Neurocritical Care
• Pharmacogenomics
• +۲ مورد دیگر

Dr. Nikitas Nikitas is an Honorary Clinical Lecturer at Peninsula Medical School, University of Plymouth, specializing in Intensive Care Medicine and Neurocritical Care. His MD and PhD research focused on pharmacogenomics and viral reactivation in critical illness. Research interests include: Neurological prognostication post-cardiac arrest using somatosensory evoked potentials Microdialysis-based tissue biochemistry monitoring Endocrine dysregulation in subarachnoid hemorrhage Pharmacogenomics of platinum-based chemotherapy Recent publications (2020-2023) show strong focus on COVID-19 critical care, neurological monitoring, and sepsis biomarkers. Clinical trials leadership includes REMAP-CAP and BLING III studies. Awards and credentials: Associate Fellowship in Intensive Care Medicine (AFICM) European Diploma in Intensive Care Medicine (EDIC) Specialty Certificates in Intensive Care/General Medicine

Roy Clarkeمشاهده پروفایل

استاد

• Materials Science
• Optoelectronics
• Semiconductor Physics
• +۳ مورد دیگر

Physicist Roy Clarke is a Professor at the University of Michigan's Department of Physics, affiliated with the Randall Laboratory and Homer A. Neal Lab. His research focuses on materials science, optoelectronics, and energy materials, with notable contributions to developing affordable energy technologies using common elements. He leads an international team advancing semiconductor and photonic materials for applications in solar energy, medical imaging, and radiation detection. Key projects include creating novel Cerenkov emission-based optical probes for tumor microenvironment analysis during radiotherapy and pioneering alloy-free bandgap engineering for optoelectronic devices. His work spans nanotechnology, topological insulators, and biomedical instrumentation. Clarke collaborates globally on energy-secure materials and has contributed to advancements in thin-film growth techniques and semiconductor characterization. He is involved in academic initiatives promoting diversity and inclusivity in STEM education. His lab addresses challenges in high-temperature superconductors, thermoelectric materials, and laser-induced nanostructures. Though not explicitly listed, his research has likely led to grants and collaborations with institutions like Fermilab and Brookhaven National Laboratory.